Publications by authors named "D Zetner"
Article Synopsis
- The study investigated risk factors for rebleeding and 30-day mortality in patients who underwent prophylactic transarterial embolization for peptic ulcer bleeding at Rigshospitalet, Denmark, from 2016 to 2021.
- Out of 176 patients, 25% experienced rebleeding and 15% died within 30 days; factors like not following a standardized embolization procedure significantly increased these risks.
- More than one endoscopy before the procedure raised rebleeding odds, while a high Rockall-score correlated with increased mortality; factors like active bleeding did not impact these outcomes.
Aim: This was a double-blind, placebo-controlled randomized study investigating whether melatonin can protect against radiation dermatitis in women receiving radiation therapy for primary breast cancer.
Methods: Patients were included before radiation therapy and followed once weekly throughout treatment with a 3-week follow-up. Patients applied 1 g of cream to the irradiated skin twice daily, consisting of either 25 mg/g melatonin and 150 mg/g dimethyl sulfoxide, or placebo.
Background: Surgical residents need structured and objective feedback to develop their skills and become capable of performing surgical procedures autonomously. A shortage of experienced surgical staff has prompted residents to seek feedback from self-assessment and peer assessments.
Objectives: We investigated whether surgical residents can reliably rate their own and their peers' basic surgical skills using the Global Rating Scale (GRS) from the Objective Structured Assessment of Technical Skills.
Introduction: The use of abbreviations in patient records in Danish hospitals is extensive. The purpose of this study was to investigate the use of abbreviations, how they affect the comprehension, and how much time was saved writing abbreviations.
Methods: The study consisted of four sub-studies.
The aim of this double-blind, placebo-controlled, randomized study was to investigate whether topical melatonin administered during radiation therapy could increase the quality of life in patients with primary breast cancer. Patients were followed from the first radiation fraction until 3 weeks after the last. The patients applied 1 g of cream to the irradiated area of the skin twice daily, consisting of either 25 mg/g melatonin and 150 mg/g dimethyl sulfoxide, or a placebo cream.
View Article and Find Full Text PDF